Cancer Research and Treatment10.4143/crt.2016.0762017491274-278Human Herpesvirus 8–Unrelated Primary Effusion Lymphoma–Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoloneJunghoon Shin, Jeong-Ok Lee, Ji-Young Choe, Soo-Mee Bang, Jong-Seok Lee,,
Hematology10.1080/10245332.2018.1509461201824152-59Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphomaKensuke Kayamori, Katsuhiro Shono, Masahiro Onoda, Akira Yokota,
Cancer10.1002/cncr.20956200510381644-1651Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphomaJohn C. Hornberger, Jennie H. Best,
European Journal of Cancer10.1016/j.ejca.2016.02.004201658112-121Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphomaMichael A. Fridrik, Ulrich Jaeger, Andreas Petzer, Wolfgang Willenbacher, Felix Keil, Alois Lang, Johannes Andel, Sonja Burgstaller, Otto Krieger, Willi Oberaigner, Kurt Sihorsch, Richard Greil,
Blood Research10.5045/br.2013.48.4.2962013484296Primary diffuse large B-cell lymphoma of the bone marrow in a frail and elderly patient successfully treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisonePasquale Niscola, Massimiliano Palombi, Stefano Fratoni, Alessio Perrotti, Paolo de Fabritiis,,
Chest10.1378/chest.198015520141464478AHuman Herpes Virus 8 - Unrelated Primary Effusion Lymphoma-Like Lymphoma: Classification, Diagnosis, and ManagementJatan Shah, Natasha Bhimani, Rachel Must-Ettinger, He Zhang,
Journal of the Korean Ophthalmological Society10.3341/jkos.2013.54.8.115720135481157The Effect of Rituximab, Cyclophosphamide, Vincristine, and Prednisolone (R-CVP) Chemotherapy in Patients with Ocular Adnexal Extranodal Marginal Zone B Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT) LymphomaSung Jin Park, Won Sik Lee, Jae Wook Yang,,
Thyroid10.1089/thy.2009.04402010204425-427Rituximab Plus Dose–Reduced Cyclophosphamide, Mitoxantrone, Vincristine, and Prednisolone Are Effective in Elderly Patients with Diffuse Large B-Cell Lymphoma of the ThyroidConstanze Jonak, Marlene Troch, Leonhard Müllauer, Bruno Niederle, Martha Hoffmann, Markus Raderer,
Clinical Lymphoma and Myeloma10.3816/clm.2008.n.042200885300-304A Case of HIV-Negative Primary Effusion Lymphoma Treated with Bortezomib, Pegylated Liposomal Doxorubicin, and RituximabTanya Siddiqi, Robin M. Joyce,
Cancer10.1002/cncr.266572011118133446-3446Erratum: Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma,